Status:

UNKNOWN

The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH

Lead Sponsor:

The Hospital for Sick Children

Collaborating Sponsors:

Children's Hospital of Philadelphia

Canadian Institutes of Health Research (CIHR)

Conditions:

Idiopathic Infantile Hypercalcemia - Mild Form

Eligibility:

All Genders

6-17 years

Phase:

PHASE1

Brief Summary

Idiopathic infantile hypercalcemia(IIH) is a rare,genetic disorder of mineral metabolism. Biallelic loss of functions mutations of CYP24A1, the gene encoding the 24-hydroxylase enzyme that represents ...

Detailed Description

Idiopathic infantile hypercalcemia(IIH) is a rare,genetic disorder of mineral metabolism characterized by severe hypercalcemia and/or hypercalciuria, suppressed serum levels of parathyroid hormone (PT...

Eligibility Criteria

Inclusion

  • all patients between 6 months- 17 years of age with the clinical phenotype of idiopathic infantile hypercalcemia
  • Biochemical evidence of this disorder: Serum calcium\>upper limit of the reference age for range; high, 1,25 (OH)D; reduced PTH, reduced 24,25(OH)2D, and suppresses 24,1,25 (OH)2D, normal serum creatinine, AST, and ALT with or without
  • biallelic inactivating mutations of CYP24A1
  • mutations in newly published genes which are shown during the course of the study to cause an inappropriate increase in 1,25 (OH)2D

Exclusion

  • Allergy to rifampin or related medications
  • Pregnancy or breastfeeding
  • Significant cardiac, hepatic, or endocrine comorbidities
  • Taking any medications/foods known to interact with CYP3A4 or 1,25 (OH)D
  • Parents or guardians or subjects who in the opinion of the Investigator may be non compliant with study schedules or procedures
  • Other comorbidities considered unsuitable by the investigator, including TB

Key Trial Info

Start Date :

February 22 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT03384121

Start Date

February 22 2018

End Date

December 31 2021

Last Update

August 31 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8